AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Stock Price Up 0.8% – Time to Buy?

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) rose 0.8% during mid-day trading on Wednesday. The company traded as high as $12.16 and last traded at $12.00. Approximately 489,818 shares changed hands during mid-day trading, a decline of 37% from the average session volume of 782,133 shares. The stock had previously closed at $11.91.

AGF U.S. Market Neutral Anti-Beta Fund Stock Down 0.9%

The stock has a fifty day simple moving average of $12.10 and a 200 day simple moving average of $12.18. The firm has a market capitalization of $307.88 million, a P/E ratio of 17.67 and a beta of -0.65.

Hedge Funds Weigh In On AGF U.S. Market Neutral Anti-Beta Fund

Institutional investors have recently bought and sold shares of the business. CoreCap Advisors LLC bought a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund during the 2nd quarter valued at approximately $36,000. Bank of New York Mellon Corp increased its position in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the first quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock valued at $380,000 after acquiring an additional 10,146 shares during the last quarter. Worth Asset Management LLC increased its position in AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the first quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock valued at $425,000 after acquiring an additional 5,190 shares during the last quarter. Farther Finance Advisors LLC raised its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 939.7% in the third quarter. Farther Finance Advisors LLC now owns 42,356 shares of the company’s stock valued at $508,000 after acquiring an additional 38,282 shares during the period. Finally, PMV Capital Advisers LLC lifted its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 14.0% in the 1st quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock worth $3,443,000 after acquiring an additional 30,234 shares during the last quarter.

AGF U.S. Market Neutral Anti-Beta Fund Company Profile

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

See Also

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.